Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Nanning Xinzizhu to Distribute AOTI Wound Healing Device in China

publication date: Jan 18, 2019

Nanning Xinzizhu Trading acquired China distribution rights to a medical device aimed at treating chronic wounds made by AOTI of Oceanside, CA. AOTI developed the Topical Wound Oxygen (TWO2) device that delivers oxygen to chronic wounds, especially diabetic ulcers. Initially, both AOTI and Xinzizhu will work together to obtain NMPA registration of the TWO2 product line, while they increase awareness of the new device. The two companies signed a multi-year agreement that includes minimum sales totaling close to $18 million. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here